Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes.
D001549:Benzamides / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004260:DNA Repair / Q000187:drug effects; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism*; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology; D009243:NAD / Q000378:metabolism; D009244:NAD+ Nucleosidase / Q000037:antagonists & inhibitors*; D009536:Niacinamide / Q000031:analogs & derivatives / Q000494:pharmacology; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011687:Purines / Q000494:pharmacology; D011718:Pyrazinamide / Q000031:analogs & derivatives
D001549:Benzamides; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D011687:Purines; D009243:NAD; D008769:Methylnitronitrosoguanidine; D009536:Niacinamide; D011718:Pyrazinamide; D004247:DNA; D009244:NAD+ Nucleosidase